Food & Drug Administration – Only 113 Characters Left In the Tweet
The FDA is on its way to regulating social media and its use by pharmaceutical companies. By July 2014, the FDA must publish its guidelines for social media use.
The FDA is faced with issuing guidelines on the appropriateness of tweeting. A 140 character tweet is likely not long enough to include all of the necessary information such as risks and side effects. Thomas Abrams, director of the FDA’s Office of Prescription Drug Promotion supports pharmaceutical companies promoting their products on Twitter if they can meet with regulatory requirements at the same time.
Different questions arise with social media such as Facebook and Pinterest. Is a company endorsing a product by “liking” or “pinning” it? The FDA cautions that such actions may raise questions of off-label promotion and adverse event reporting, and it has already warned companies for such practices. Much of the regulation appears to be dependent on how much the company is working to influence and disseminate the information shared on social media.
For more information, visit FDA To Help Drugmakers Take To Twitter, Official Says (Note: Subscription required to view full article)